The following information is available to be viewed/printed in Adobe Acrobat pdf format



Integrative medicine implies practicing medicine in a way that selectively incorporates elements of complementary and alternative medicine, including traditional Chinese medicine, into comprehensive treatment plans alongside orthodox methods of diagnosis and treatment.


The Journal of Chinese Integrative Medicine (JCIM) or Zhong Xi Yi Jie He Xue Bao (Phonetic romanization of the Chinese title, also the journal title and title abbreviation used by MEDLINE/PubMed) is the official journal of the Shanghai Association of Integrative Medicine. JCIM is indexed/abstracted in MEDLINE/PubMed.

JCIM is a peer-reviewed open access journal and is listed in the Directory of Open Access Journals (DOAJ). Both print and online issues of JCIM are published monthly. The full texts (HTML and PDF) are made freely available online at All articles are citable by DOI number and are searchable at PubMed with free full-text LinkOut. This ensures that the articles published in JCIM have maximum exposure to the international scholarly community.

Please access all free issues online at Send your postal address by e-mail to and we will send you a complimentary print issue upon receipt.


3.1  Scope of Contributions.  JCIM welcomes manuscripts in Chinese or English on all aspects of integrative medicine from any part of the world. Reviews, systematic reviews, methodology, study protocols, and original research articles (both basic science studies and clinical trials) are especially welcome. Commentaries, short reports, case reports, book reviews, conference summaries, and letters to the editor are also accepted.

3.2 Manuscript Submission. Manuscripts should be submitted online at or at via ScholarOne Manuscripts. Manuscripts should be accompanied by a cover letter giving details of 1) the title of the manuscript; 2) a statement that the manuscript has not been published in part or whole (except in the form of an abstract) or is not under consideration for publication elsewhere in any language; 3) a statement that all authors have agreed to be so listed and have seen and approved the manuscript and its submission to JCIM; 4) a full postal address, telephone and fax numbers, and e-mail address for each author; 5) a declaration of financial arrangements or relationships that may pose conflict of interest.

Illustrations such as figures, graphics and tables can be embedded in the text file or may be sent in separate files, preferably the former if possible.


4.1  Manuscript Receipt.  Upon the receipt of the manuscript, the JCIM Editorial Office will assign a code number, which is to be used in all subsequent correspondence.

4.2  Review.  A member of the editorial staff or designated advisory board member will determine whether the manuscript warrants further peer review, in which case the manuscript will be sent to at least two outside referees. The peer-review process takes approximately one month. Based on the comments of the reviewers, the journal editor determines whether the manuscript is accepted, rejected, or requires revision before publication, and the decision will be sent to the authors.

4.3  Revision.  If revision is required, the authors should amend and resubmit the manuscript within 30 days. Resubmission after 30 days may be considered as a new submission. If the revision is not satisfactory to the reviewers, the author may be asked to make a second revision. Articles are normally published within 3 months of acceptance.

4.4  Rejected Manuscripts.  If a manuscript is not accepted, the authors will receive a decision letter that may or may not include the reviewers’ comments.

4.5  Proofreading.  The corresponding author of a manuscript to be published will receive proofs. Checking the proofs is solely the authors’ responsibility. The publisher is not responsible for any errors not marked by the author on the proof. The proof must be returned to the Editorial Office within 7 days of receipt.

4.6  Costs.  No charge will be levied on manuscripts written in English. Page charges are only required for manuscripts written in Chinese from within China.


These guidelines are in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication”. Recent issues of JCIM should be consulted for examples.

5.1  Title Page.   The title page should carry the following information: 1) title of the article; 2) name and institutional affiliation of each author; 3) the designated corresponding author’ s name, mailing address, telephone and fax numbers, and e-mail address; 4) source(s) of financial support of the study.

5.2  Original Research Articles

5.2.1  Abstract.  An abstract of about 250 words should follow the title page. Abstracts of randomized controlled trials (RCTs) should consist of six paragraphs, labeled Background, Objective, Design, setting, participants and interventions, Main outcome measures, Results, and Conclusion. Abstracts of original experimental research papers should consist of four paragraphs, labeled Objective, Methods, Results and Conclusion.

5.2.2  Keywords.  On the abstract page, authors should provide 3 to 10 keywords that capture the main topics of the article. Terms from Medical Subject Headings (MeSH) list of MEDLINE/PubMed should be used.

5.2.3  Text.  Word count for original research manuscripts should be no more than 4 000 words in English, or 6 000 words in Chinese. The text is usually divided into sections with headings such as Introduction, Materials and Methods, Results, and Discussion. For reports of randomized controlled trials authors should refer to the CONSORT 2010 Statement, which can be found at

5.2.4  Ethics.  When reporting experiments on human subjects or animals, the authors should include a statement in the Materials section. Human experiments must be performed in accordance with international ethical standards such as the Declaration of Helsinki, and the research protocol must be approved by an institutional review board (IRB) or equivalent human ethics committee. Documented informed consent must be obtained from all human subjects of clinical research prior to any experiment; the confidentiality of patients’ information must be preserved and a statement to that effect must be included. Laboratory research involving animals must comply with guidelines for animal care and use; the experimental protocol must be approved by the institutional animal care and use committee (IACUC), and a statement to that effect must be included.

5.2.5  Statistical Methods.  Statistical methods should be described in sufficient detail to enable a knowledgeable reader to assess the appropriateness of the statistical analysis used. Statistical terms, abbreviations, and symbols must be defined, and computer software must be specified. Lacunae in observations, such as dropouts from the study, should be reported, and the intend-to-treat method should be applied.

5.2.6  Tables.  Number tables consecutively in the order of their first citation in the text and supply a brief title for each table. Abbreviations must be defined in notes. Identify statistical measures of variations, such as standard deviation and standard error of the mean. Identify statistical significance by superscripts in front of the probabilities (P), as in: aP>0.05, bP<0.05, cP<0.01 vs A. If you use data from another published source, obtain permission and acknowledge them fully.

5.2.7  Figures.  Number figures consecutively in the text. Figures should be professionally drawn or photographed. Drawings must be of an acceptably high standard, and only letter-set printed material (not freehand or typewritten) should be employed. Letters, numbers, and symbols on figures should be clear. Titles and detailed explanations should be given in the figure legend. Photomicrographs should have internal scale markers.

Legends for figures should be printed out with Arabic numerals corresponding to the illustrations. Explain the internal scale and identify the method of staining and magnification of photomicrographs. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Abbreviations must be explained.

If photographs of people are used, either the subjects must not be identifiable or written permission from the depicted individuals must be included. If a figure has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material.

5.2.8  Acknowledgments.  Acknowledgment(s) may briefly include assistance from 1) contributors that do not warrant authorship, 2) technical help, and 3) material support, as well as 4) financial support such as a grant.

5.2.9  References.  Authors should check the accuracy of all reference citations. Unpublished data, classified periodicals, and personal communications may not be used as references. References should be numbered consecutively in the order in which they are first cited in the text. Identify references in text, tables, and legends by superscript of Arabic numerals in parentheses.

The titles of journals should be abbreviated according to the style used in MEDLINE/PubMed. List all of the authors (surname, initials), title of the article, name of the journal or book, year, volume (issue) and the first and last pages.

5.3  Other Types of Articles

5.3.1  Review Articles.  Research review and systematic review articles are welcome and undergo the same peer-review and editorial process as original research reports. A research review article discusses a focused topic of recent research in integrative medicine, with commentary and analysis concerning the topic; a single-paragraph summary of fewer than 150 words should be included. For systematic reviews authors should refer to the PRISMA Statement, which can be found at The author(s) of a review article should provide a comprehensive and critical but balanced view of the field. Review papers may be up to 5 000 words in English or 6 000 words in Chinese.

5.3.2  Study Protocols.  Study protocol should be for a proposed or ongoing RCT. It should follow the CONSORT guidelines and must have a trial registration number. Study protocols will usually be published without peer review if the study has received ethics approval and a grant from a major funding body (proof will be required). Study protocols without funding or ethical approval will be peer reviewed. A manuscript for study protocol should be divided into the following sections: Title Page, Abstract (consists of 4 paragraphs, labeled as Background, Methods/Design, Discussion, and Trial Registration ), Keywords, Background and Significance/Preliminary Studies, Study Aims, Study Design/Methods, Discussion, Competing interests, Authors’ contributions, Acknowledgements and Funding, and References. Publishing your study protocol in JCIM does not commit you to submitting subsequent reports of the study to us, although we do, of course, welcome such submissions.

5.3.3  Case Reports.  Case reports will be considered if of particular interest. These should be less than 800 words, do not include an abstract, and should include a brief introduction and concise discussion describing the value of the report.

5.3.4  Short Reports.  Short communications should be no more than 2 000 words in English or 3 000 words in Chinese, including title, author affiliations, references, and one figure or table. They do not include an abstract.

5.3.5  Letters to the Editor.  Letters to the editor should be no more than 1 000 words in English or 1 500 words in Chinese. Preference is given to criticisms or comments related to articles published in JCIM.

5.4  Notices.  Announcements of forthcoming regional conferences will be published free of charge. Please specify the title of the meeting, the dates and venue, organizers, and correspondence or secretariat address.


Editorial Office

Journal of Chinese Integrative Medicine

Room 1407, Building of Science and Technology

No.168, Changhai Road, Shanghai 200433, China

Phn/Fax: 86-21-81873540

E-mail: or